Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer

被引：0
作者：
Suguru Yamada
Tsutomu Fujii
Yukihiro Yokoyama
Hiroki Kawashima
Osamu Maeda
Kojiro Suzuki
Tohru Okada
Eizaburo Ono
Junpei Yamaguchi
Nao Takano
Hideki Takami
Masamichi Hayashi
Yukiko Niwa
Yoshiki Hirooka
Yoshiyuki Ito
Shinji Naganawa
Yuichi Ando
Masato Nagino
Hidemi Goto
Yasuhiro Kodera
机构：
[1] Nagoya University Graduate School of Medicine,Department of Gastroenterological Surgery (Surgery II)
[2] University of Toyama,Department of Surgery and Science, Graduate School of Medicine and Pharmaceutical Sciences
[3] Nagoya University Graduate School of Medicine,Division of Surgical Oncology, Department of Surgery
[4] Nagoya University Graduate School of Medicine,Department of Gastroenterology and Hepatology
[5] Nagoya University Hospital,Department of Clinical Oncology and Chemotherapy
[6] Aichi Medical University,Department of Radiology
[7] Nagoya University Graduate School of Medicine,Department of Radiology
[8] Nagoya University Hospital,Department of Endoscopy
来源：
Cancer Chemotherapy and Pharmacology | 2018年 / 81卷
关键词：
Phase I study; Gemcitabine; Nab-paclitaxel; Radiation; Unresectable locally advanced pancreatic cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：815 / 821
页数：6
相关论文
共 50 条
[41]   A Modified Regimen of 21-day Nab-Paclitaxel Plus Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer: A Retrospective Real-World Study [J].
Chang, Chen ;
Meng, Lingwei ;
Li, Xiaofen ;
Cheng, Ke ;
Yi, Cheng ;
Peng, Bing ;
Ma, Ji ;
Cao, Dan .
CANCER CONTROL, 2022, 29
[42]   A Modified Regimen of 21-day Nab-Paclitaxel Plus Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer: A Retrospective Real-World Study [J].
Chang, Chen ;
Meng, Lingwei ;
Li, Xiaofen ;
Cheng, Ke ;
Yi, Cheng ;
Peng, Bing ;
Ma, Ji ;
Cao, Dan .
CANCER CONTROL, 2022, 29
[43]   A Modified Regimen of 21-day Nab-Paclitaxel Plus Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer: A Retrospective Real-World Study [J].
Chang, Chen ;
Meng, Lingwei ;
Li, Xiaofen ;
Cheng, Ke ;
Yi, Cheng ;
Peng, Bing ;
Ma, Ji ;
Cao, Dan .
CANCER CONTROL, 2022, 29
[44]   Nab-paclitaxel plus S-1 versus nab-paclitaxel plus gemcitabine as first-line chemotherapy in patients with advanced pancreatic ductal adenocarcinoma: a randomized study [J].
Yuan Zong ;
Jiajia Yuan ;
Zhi Peng ;
Ming Lu ;
Xicheng Wang ;
Lin Shen ;
Jun Zhou .
Journal of Cancer Research and Clinical Oncology, 2021, 147 :1529-1536
[45]   Nab-paclitaxel plus S-1 versus nab-paclitaxel plus gemcitabine as first-line chemotherapy in patients with advanced pancreatic ductal adenocarcinoma: a randomized study [J].
Zong, Yuan ;
Yuan, Jiajia ;
Peng, Zhi ;
Lu, Ming ;
Wang, Xicheng ;
Shen, Lin ;
Zhou, Jun .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (05) :1529-1536
[46]   Feasibility of Combination Therapy with Nab-paclitaxel Plus Gemcitabine in Patients with Recurrent Pancreatic Cancer [J].
Kawaida, Hiromichi ;
Kono, Hiroshi ;
Amemiya, Hidetake ;
Saitou, Ryou ;
Yamamoto, Atsushi ;
Hosomura, Naohiro ;
Watanabe, Mitsuaki ;
Kimura, Ayako ;
Furuya, Shinji ;
Shimizu, Hiroki ;
Akaike, Hidenori ;
Kawaguchi, Yoshihiko ;
Sudo, Makoto ;
Itakura, Jun ;
Hayakawa, Hiroshi ;
Shindo, Hiroko ;
Takahashi, Ei ;
Takano, Shinichi ;
Fukasawa, Mitsuharu ;
Ichikawa, Shintaro ;
Fujii, Hideki ;
Ichikawa, Daisuke .
ANTICANCER RESEARCH, 2018, 38 (11) :6537-6542
[47]   Phase I/II study of nab-paclitaxel plus gemcitabine for chemotherapy-naive Japanese patients with metastatic pancreatic cancer [J].
Hideki Ueno ;
Masafumi Ikeda ;
Makoto Ueno ;
Nobumasa Mizuno ;
Tatsuya Ioka ;
Yasushi Omuro ;
Takako Eguchi Nakajima ;
Junji Furuse .
Cancer Chemotherapy and Pharmacology, 2016, 77 :595-603
[48]   Quality of life study of patients with unresectable locally advanced or metastatic pancreatic adenocarcinoma treated with gemcitabine plus nab-paclitaxel versus gemcitabine alone: AX-PANC-SY001, a randomized phase-2 study [J].
Yalcin, Suayib ;
Dane, Faysal ;
Oksuzoglu, Berna ;
Ozdemir, Nuriye Yildirim ;
Isikdogan, Abdurrahman ;
Ozkan, Metin ;
Demirag, Guzin Gonullu ;
Coskun, Hasan Senol ;
Karabulut, Bulent ;
Evrensel, Turkkan ;
Ustaoglu, Mehmet Ali ;
Ozdemir, Feyyaz ;
Turna, Hande ;
Yavuzsen, Tugba ;
Aykan, Faruk ;
Sevinc, Alper ;
Akbulut, Hakan ;
Yuce, Deniz ;
Hayran, Mutlu ;
Kilickap, Saadettin .
BMC CANCER, 2020, 20 (01)
[49]   Gemcitabine plus nab-paclitaxel followed by maintenance treatment with gemcitabine alone as first-line treatment for older adults with locally advanced or metastatic pancreatic cancer [J].
Petrioli, Roberto ;
Torre, Pamela ;
Pesola, Guido ;
Paganini, Giovanni ;
Paolelli, Loretta ;
Miano, Salvatora Tindara ;
Martellucci, Ignazio ;
Francini, Guido ;
Francini, Edoardo .
JOURNAL OF GERIATRIC ONCOLOGY, 2020, 11 (04) :647-651
[50]   Treatment outcomes of gemcitabine plus nab-paclitaxel in pancreatic cancer patients with malignant ascites [J].
Inoue, Kanae ;
Fukushi, Koh ;
Yamaguchi, Shota ;
Taira, Tomonao ;
Shibuki, Taro ;
Satake, Tomoyuki ;
Watanabe, Kazuo ;
Sasaki, Mitsuhito ;
Imaoka, Hiroshi ;
Mitsunaga, Shuichi ;
Ikeda, Masafumi .
PANCREATOLOGY, 2024, 24 (04) :616-623
12345